HSY Hershey Company (The)
Margins are already back; at $178, the market prices in more growth than a mature chocolate franchise delivers.
The story
Hershey is a durable North American confectionery franchise with strong brands, shelf-space power, and pricing ability, plus a growing salty-snacks arm. It is a mature, low-growth business coming out of a cocoa cost shock. Trailing operating margin is already back to about 20.7% as cocoa costs ease and price increases stick. The open question is no longer whether margins recover but how much volume holds up under GLP-1 drugs and shoppers pushing back on higher prices.
I kept growth, reinvestment, risk and horizon unchanged. Trailing revenue grew about 4.9%, mostly from pricing, and actual sales-to-capital is 1.23, close to my 1.3. I raised the target margin slightly to 21% (from 20.5%, a 2% relative change) and cut margin_years from 3 to 2, because the margin recovery to 20.7% has already happened and cocoa has come off its peak; 21% still sits below the 23.6% peak year. A 7-year horizon fits a strong but mature franchise with a limited reinvestment runway.
Value drivers
| Revenue growth (Y1) | 4.5% |
| Terminal growth | 2.5% |
| Forecast horizon | 7y |
| Target operating margin | 21.0% |
| Years to target margin | 2 |
| Sales-to-capital | 1.30 |
| Beta | 0.70 |
| Failure probability | 1.0% |
| Cost of capital (WACC) | 7.6% |
| Terminal WACC | 8.7% |
Valuation bridge
| PV of explicit FCFF | 9.43B |
| PV of terminal value | 19.48B |
| Equity value | 24.26B |
| ÷ shares → per share | $120.73 |
Projected free cash flow to the firm
| Yr | Revenue | Growth | Margin | NOPAT | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | 12.81B | 4.5% | 20.9% | 1.94B | 424.32M | 1.52B | 1.41B |
| 2 | 13.34B | 4.2% | 21.0% | 2.04B | 410.56M | 1.63B | 1.41B |
| 3 | 13.85B | 3.8% | 21.0% | 2.12B | 393.46M | 1.72B | 1.38B |
| 4 | 14.34B | 3.5% | 21.0% | 2.19B | 373.02M | 1.82B | 1.36B |
| 5 | 14.79B | 3.2% | 21.0% | 2.26B | 349.30M | 1.91B | 1.33B |
| 6 | 15.21B | 2.8% | 21.0% | 2.32B | 322.43M | 2.00B | 1.29B |
| 7 | 15.59B | 2.5% | 21.0% | 2.38B | 292.56M | 2.09B | 1.25B |
Key risks
- Cocoa prices spike again and squeeze margins
- Volume losses from GLP-1 drugs and shoppers trading down
- Retailer pushback on pricing and a shift toward private label
Catalysts
- Lower-cost cocoa contracts reaching cost of goods in 2027
- Salty-snacks growth and productivity savings supporting margins above 21%